Marinomed Biotech AG (MARI.VI)

EUR 13.0

(-1.89%)

Long Term Debt Summary of Marinomed Biotech AG

Marinomed Biotech AG's latest annual long term debt in 2023 was 14.84 Million EUR , down -26.47% from previous year.
Marinomed Biotech AG's latest quarterly long term debt in 2024 Q1 was 21.14 Million EUR , up 42.52% from previous quarter.
Marinomed Biotech AG reported annual long term debt of 20.18 Million EUR in 2022, up 34.15% from previous year.
Marinomed Biotech AG reported annual long term debt of 15.04 Million EUR in 2021, up 20.77% from previous year.
Marinomed Biotech AG reported quarterly long term debt of 14.84 Million EUR for 2023 Q4, down -23.29% from previous quarter.
Marinomed Biotech AG reported quarterly long term debt of 19.5 Million EUR for 2023 Q2, down -2.87% from previous quarter.

Annual Long Term Debt Chart of Marinomed Biotech AG (2023 - 2015)

Historical Annual Long Term Debt of Marinomed Biotech AG (2023 - 2015)

Year	Long Term Debt	Long Term Debt Growth
2023	14.84 Million EUR	-26.47%
2022	20.18 Million EUR	34.15%
2021	15.04 Million EUR	20.77%
2020	12.45 Million EUR	176.49%
2019	4.5 Million EUR	-33.32%
2018	6.75 Million EUR	12.1%
2017	6.02 Million EUR	49.64%
2016	4.02 Million EUR	-10.75%
2015	4.51 Million EUR	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q1	21.14 Million EUR	42.52%
2023 Q4	14.84 Million EUR	-23.29%
2023 Q2	19.5 Million EUR	-2.87%
2023 Q3	19.34 Million EUR	-0.82%
2023 Q1	20.08 Million EUR	-0.5%
2023 FY	14.84 Million EUR	-26.47%
2022 FY	20.18 Million EUR	34.15%
2022 Q4	20.18 Million EUR	-3.8%
2022 Q3	20.97 Million EUR	-0.57%
2022 Q2	21.09 Million EUR	1.08%
2022 Q1	20.87 Million EUR	38.74%
2021 FY	15.04 Million EUR	20.77%
2021 Q2	12.94 Million EUR	1.23%
2021 Q4	15.04 Million EUR	7.02%
2021 Q3	14.05 Million EUR	8.62%
2021 Q1	12.78 Million EUR	2.63%
2020 Q3	4.74 Million EUR	1.05%
2020 Q2	4.69 Million EUR	1.08%
2020 Q1	4.64 Million EUR	3.16%
2020 FY	12.45 Million EUR	176.49%
2020 Q4	12.45 Million EUR	162.41%
2019 FY	4.5 Million EUR	-33.32%
2019 Q4	4.5 Million EUR	880.08%
2019 Q3	459.69 Thousand EUR	2.08%
2019 Q2	450.34 Thousand EUR	-62.91%
2019 Q1	1.21 Million EUR	-82.03%
2018 Q4	6.75 Million EUR	2.77%
2018 FY	6.75 Million EUR	12.1%
2018 Q3	6.57 Million EUR	0.0%
2017 Q4	6.02 Million EUR	0.0%
2017 FY	6.02 Million EUR	49.64%
2016 FY	4.02 Million EUR	-10.75%
2015 FY	4.51 Million EUR	0.0%

Peer Long Term Debt Comparison of Marinomed Biotech AG

Name	Long Term Debt	Long Term Debt Difference